For instance, nanoparticle-based delivery systems, such as gold nanoparticles or polymeric nanoparticles, have been engineered to bind specifically to receptors like vascular cell adhesion molecule-1 (VCAM-1) on endothelial cells, enabling localized drug delivery to sites of vascular injury or tumor angiogenesis. This evidence concerns the gene VCAM1 and neoplasm.